ArticleScience advances2026
Interfacial solvothermal synthesis of superhydrophilic ionic salt-derived chiral helical COFs with strong chiroptical activity.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional chiral induction strategies for nonionic covalent organic frameworks (COFs) often produce disordered aggregates with low dissymmetry factors and weak chiroptical activity due to uncontrolled crystallization kinetics. Here, we report an interfacial solvothermal strategy that spatially separates superhydrophilic ionic amines in an aqueous phase from aldehyde monomers in an organic phase, enabling precise kinetic regulation and efficient molecular-to-mesoscale chiral amplification. This method yields highly ordered helical ionic COFs, including anionic, cationic, and zwitterionic frameworks, with outstanding chiroptical properties, featuring ellipticities exceeding 3600 millidegrees (mdeg) and |
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.